The Asia Pacific Transcriptomics Market would witness market growth of 8.3% CAGR during the forecast period (2021-2027).
Transcriptomics is the exploration of the transcriptome, which is the entire set of RNA transcripts produced by the genome under certain conditions or in a specific cell, utilizing high-throughput technologies like microarray analysis. In addition, genes that are differentially expressed in different cell groups or in response to different treatments can be identified by comparing transcriptomes.
Rising R&D spending in transcriptomic technologies by pharmaceutical and biotechnology companies, as well as increased demand for tailored medication in cancer treatment, are driving the growth of the RNA analysis/transcriptomics market. Additionally, Oxford Brookes University recognized the development of improved single-cell transcriptomic technologies in April 2021. These technologies evaluate several individual cells from living creatures and sequence each cell's genetic material. According to the study, this procedure allows scientists to swap samples between labs, maintain the material, and freeze sample sets to examine at the same time without harming the cell's quality.
Governments and businesses are increasing their funding for biotechnology research in Asia Pacific countries. In addition, the Japanese government and non-government groups are enthusiastic about the advancement of biotechnology research in Japan, and they sponsor research in health and the life sciences. This pushes scientists to go deeper into the transcriptomics field. Furthermore, the increased focus on Asia Pacific nations is likely to give growth prospects for manufacturers due to low-cost manufacturing services. Moreover, the leading players of the regional market have shifted their attention to emerging markets and begun to build a robust position in the market through various strategic efforts, such as acquisitions.
The growing applications of Transcriptomics in Human and pathogen transcriptomes would boost its usage in the regional market. The majority of transcriptomic research has focused on either the host or the pathogen.
The China market dominated the Asia Pacific Transcriptomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $705.9 million by 2027. The Japan market is anticipated to grow at a CAGR of 7.7% during (2021 - 2027). Additionally, The India market would display a CAGR of 9% during (2021 - 2027).
Based on Technology, the market is segmented into q PCR, Microarrays, and Sequencing Technology. Based on Application, the market is segmented into Drug Discovery, Diagnostics & Disease Profiling, and Others. Based on Component, the market is segmented into Consumables, Instruments, Software, and Services. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Transcriptomics Market is Projected to reach USD 9.4 Billion by 2027, at a CAGR of 7.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Promega Corporation, General Electric (GE) Co., Merck & Co., Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., and Qiagen N.V.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- q PCR
- Microarrays
- Sequencing Technology
By Application
- Drug Discovery
- Diagnostics & Disease Profiling
- Others
By Component
- Consumables
- Instruments
- Software
- Services
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Fluidigm Corporation
- Promega Corporation
- General Electric (GE) Co.
- Merck & Co., Inc.
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Qiagen N.V.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Transcriptomics Market, by Technology
1.4.2 Asia Pacific Transcriptomics Market, by Application
1.4.3 Asia Pacific Transcriptomics Market, by Component
1.4.4 Asia Pacific Transcriptomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan – 2021, Apr) Leading Players
3.3.3 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar – 2021, Nov) Leading Players
Chapter 4. Asia Pacific Transcriptomics Market by Technology
4.1 Asia Pacific q PCR Market by Country
4.2 Asia Pacific Microarrays Market by Country
4.3 Asia Pacific Sequencing Technology Market by Country
Chapter 5. Asia Pacific Transcriptomics Market by Application
5.1 Asia Pacific Drug Discovery Market by Country
5.2 Asia Pacific Diagnostics & Disease Profiling Market by Country
5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Transcriptomics Market by Component
6.1 Asia Pacific Consumables Market by Country
6.2 Asia Pacific Instruments Market by Country
6.3 Asia Pacific Software Market by Country
6.4 Asia Pacific Services Market by Country
Chapter 7. Asia Pacific Transcriptomics Market by Country
7.1 China Transcriptomics Market
7.1.1 China Transcriptomics Market by Technology
7.1.2 China Transcriptomics Market by Application
7.1.3 China Transcriptomics Market by Component
7.2 Japan Transcriptomics Market
7.2.1 Japan Transcriptomics Market by Technology
7.2.2 Japan Transcriptomics Market by Application
7.2.3 Japan Transcriptomics Market by Component
7.3 India Transcriptomics Market
7.3.1 India Transcriptomics Market by Technology
7.3.2 India Transcriptomics Market by Application
7.3.3 India Transcriptomics Market by Component
7.4 South Korea Transcriptomics Market
7.4.1 South Korea Transcriptomics Market by Technology
7.4.2 South Korea Transcriptomics Market by Application
7.4.3 South Korea Transcriptomics Market by Component
7.5 Singapore Transcriptomics Market
7.5.1 Singapore Transcriptomics Market by Technology
7.5.2 Singapore Transcriptomics Market by Application
7.5.3 Singapore Transcriptomics Market by Component
7.6 Malaysia Transcriptomics Market
7.6.1 Malaysia Transcriptomics Market by Technology
7.6.2 Malaysia Transcriptomics Market by Application
7.6.3 Malaysia Transcriptomics Market by Component
7.7 Rest of Asia Pacific Transcriptomics Market
7.7.1 Rest of Asia Pacific Transcriptomics Market by Technology
7.7.2 Rest of Asia Pacific Transcriptomics Market by Application
7.7.3 Rest of Asia Pacific Transcriptomics Market by Component
Chapter 8. Company Profiles
8.1 Fluidigm Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.2 Promega Corporation
8.2.1 Company Overview
8.3 General Electric (GE) Co. (GE Healthcare)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Merck & Co., Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Thermo Fisher Scientific, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Illumina, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.8 Agilent Technologies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Qiagen N.V.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Acquisition and Mergers:
TABLE 1 Asia Pacific Transcriptomics Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Transcriptomics Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Transcriptomics Market
TABLE 4 Product Launches And Product Expansions – Transcriptomics Market
TABLE 5 Acquisition and Mergers– Transcriptomics Market
TABLE 6 Asia Pacific Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 7 Asia Pacific Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 8 Asia Pacific q PCR Market by Country, 2017 - 2020, USD Million
TABLE 9 Asia Pacific q PCR Market by Country, 2021 - 2027, USD Million
TABLE 10 Asia Pacific Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 11 Asia Pacific Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 12 Asia Pacific Sequencing Technology Market by Country, 2017 - 2020, USD Million
TABLE 13 Asia Pacific Sequencing Technology Market by Country, 2021 - 2027, USD Million
TABLE 14 Asia Pacific Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 15 Asia Pacific Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 16 Asia Pacific Drug Discovery Market by Country, 2017 - 2020, USD Million
TABLE 17 Asia Pacific Drug Discovery Market by Country, 2021 - 2027, USD Million
TABLE 18 Asia Pacific Diagnostics & Disease Profiling Market by Country, 2017 - 2020, USD Million
TABLE 19 Asia Pacific Diagnostics & Disease Profiling Market by Country, 2021 - 2027, USD Million
TABLE 20 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 21 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 22 Asia Pacific Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 23 Asia Pacific Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 24 Asia Pacific CONSUMABLES MARKET by Country, 2017 - 2020, USD Million
TABLE 25 Asia Pacific CONSUMABLES MARKET by Country, 2021 - 2027, USD Million
TABLE 26 Asia Pacific INSTRUMENTS MARKET by Country, 2017 - 2020, USD Million
TABLE 27 Asia Pacific Instruments Market by Country, 2021 - 2027, USD Million
TABLE 28 Asia Pacific SOFTWARE MARKET by Country, 2017 - 2020, USD Million
TABLE 29 Asia Pacific SOFTWARE MARKET by Country, 2021 - 2027, USD Million
TABLE 30 Asia Pacific Services Market by Country, 2017 - 2020, USD Million
TABLE 31 Asia Pacific Services Market by Country, 2021 - 2027, USD Million
TABLE 32 Asia Pacific Transcriptomics Market by Country, 2017 - 2020, USD Million
TABLE 33 Asia Pacific Transcriptomics Market by Country, 2021 - 2027, USD Million
TABLE 34 China Transcriptomics Market, 2017 - 2020, USD Million
TABLE 35 China Transcriptomics Market, 2021 - 2027, USD Million
TABLE 36 China Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 37 China Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 38 China Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 39 China Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 40 China Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 41 China Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 42 Japan Transcriptomics Market, 2017 - 2020, USD Million
TABLE 43 Japan Transcriptomics Market, 2021 - 2027, USD Million
TABLE 44 Japan Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 45 Japan Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 46 Japan Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 47 Japan Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 48 Japan Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 49 Japan Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 50 India Transcriptomics Market, 2017 - 2020, USD Million
TABLE 51 India Transcriptomics Market, 2021 - 2027, USD Million
TABLE 52 India Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 53 India Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 54 India Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 55 India Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 56 India Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 57 India Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 58 South Korea Transcriptomics Market, 2017 - 2020, USD Million
TABLE 59 South Korea Transcriptomics Market, 2021 - 2027, USD Million
TABLE 60 South Korea Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 61 South Korea Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 62 South Korea Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 63 South Korea Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 64 South Korea Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 65 South Korea Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 66 Singapore Transcriptomics Market, 2017 - 2020, USD Million
TABLE 67 Singapore Transcriptomics Market, 2021 - 2027, USD Million
TABLE 68 Singapore Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 69 Singapore Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 70 Singapore Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 71 Singapore Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 72 Singapore Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 73 Singapore Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 74 Malaysia Transcriptomics Market, 2017 - 2020, USD Million
TABLE 75 Malaysia Transcriptomics Market, 2021 - 2027, USD Million
TABLE 76 Malaysia Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 77 Malaysia Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 78 Malaysia Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 79 Malaysia Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 80 Malaysia Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 81 Malaysia Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 82 Rest of Asia Pacific Transcriptomics Market, 2017 - 2020, USD Million
TABLE 83 Rest of Asia Pacific Transcriptomics Market, 2021 - 2027, USD Million
TABLE 84 Rest of Asia Pacific Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 85 Rest of Asia Pacific Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 86 Rest of Asia Pacific Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 87 Rest of Asia Pacific Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 88 Rest of Asia Pacific Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 89 Rest of Asia Pacific Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 90 Key Information – Fluidigm Corporation
TABLE 91 key Information – Promega Corporation
TABLE 92 Key Information – General Electric (GE) Co.
TABLE 93 KEY INFORMATION - MERCK & CO., INC.
TABLE 94 Key Information – Thermo Fisher Scientific, Inc.
TABLE 95 key information – Illumina, Inc.
TABLE 96 Key Information – Bio-Rad Laboratories, Inc.
TABLE 97 key Information – Agilent Technologies, Inc.
TABLE 98 key information – F. Hoffmann-La Roche Ltd.
TABLE 99 Key Information – Qiagen N.V.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan – 2021, Apr) Leading Players
FIG 5 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar – 2021, Nov) Leading Players
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Bio-Rad Laboratories, Inc.
FIG 8 Recent strategies and developments: Qiagen N.V.